Alexion Pharmaceuticals (ALXN) PT Raised to $163 at SVB Leerink
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
SVB Leerink analyst Geoffrey Porges raised the price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $163.00 (from $159.00) while maintaining a Outperform rating.
You May Also Be Interested In
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
- Info Edge India (INFOE:IN) PT Raised to INR1,260 at Macquarie
- Sunac China Holdings Limited (1918:HK) (SCCCF) PT Lowered to HK$0.30 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
